Perfetti V - Search Results

1

Application of monoclonal anti-idiotypes in the study of AL amyloidosis: therapeutic implications.

Bellotti V, Stoppini M, Perfetti V, Zorzoli I, Marinone G, Maggi A, Invernizzi R, Arbustini E, Merlini G. Bellotti V, et al. Among authors: perfetti v. Ren Fail. 1993;15(3):365-71. doi: 10.3109/08860229309054946. Ren Fail. 1993. PMID: 8516492 Free article.

2

Use of an anti-idiotypic monoclonal antibody in studying amyloidogenic light chains in cells, urine and fibrils: pathophysiology and clinical implications.

Bellotti V, Stoppini M, Perfetti V, Zorzoli I, Marinone G, Invernizzi R, Zambelli LM, Arbustini E, Grasso M, Ferri G, et al. Bellotti V, et al. Among authors: perfetti v. Scand J Immunol. 1992 Oct;36(4):607-15. doi: 10.1111/j.1365-3083.1992.tb03229.x. Scand J Immunol. 1992. PMID: 1411304

3

AL amyloidosis. Characterization of amyloidogenic cells by anti-idiotypic monoclonal antibodies.

Perfetti V, Bellotti V, Garini P, Zorzoli I, Rovati B, Marinone MG, Ippoliti G, Merlini G. Perfetti V, et al. Lab Invest. 1994 Dec;71(6):853-61. Lab Invest. 1994. PMID: 7807967

4

Diagnostic approach to and follow-up of difficult cases of AL amyloidosis.

Perfetti V, Garini P, Vignarelli MC, Marinone MG, Zorzoli I, Merlini G. Perfetti V, et al. Haematologica. 1995 Sep-Oct;80(5):409-15. Haematologica. 1995. PMID: 8566880

5

Therapy and management of systemic AL (primary) amyloidosis.

Palladini G, Perfetti V, Merlini G. Palladini G, et al. Among authors: perfetti v. Swiss Med Wkly. 2006 Nov 11;136(45-46):715-20. doi: 10.4414/smw.2006.11479. Swiss Med Wkly. 2006. PMID: 17183435 Free article. Review.

6

Relevance of class, molecular weight and isoelectric point in predicting human light chain amyloidogenicity.

Bellotti V, Merlini G, Bucciarelli E, Perfetti V, Quaglini S, Ascari E. Bellotti V, et al. Among authors: perfetti v. Br J Haematol. 1990 Jan;74(1):65-9. doi: 10.1111/j.1365-2141.1990.tb02539.x. Br J Haematol. 1990. PMID: 2106912

7

Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils: inhibition of amyloidogenesis.

Merlini G, Ascari E, Amboldi N, Bellotti V, Arbustini E, Perfetti V, Ferrari M, Zorzoli I, Marinone MG, Garini P, et al. Merlini G, et al. Among authors: perfetti v. Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2959-63. doi: 10.1073/pnas.92.7.2959. Proc Natl Acad Sci U S A. 1995. PMID: 7708755 Free PMC article.

8

Reversal of nephrotic syndrome due to reactive amyloidosis (AA-type) after excision of localized Castleman's disease.

Perfetti V, Bellotti V, Maggi A, Arbustini E, De Benedetti F, Paulli M, Marinone MG, Merlini G. Perfetti V, et al. Am J Hematol. 1994 Jul;46(3):189-93. doi: 10.1002/ajh.2830460306. Am J Hematol. 1994. PMID: 7910717

9

Immunochemical characterization of the cryoglobulins: pathophysiologic implications.

Merlini G, Zorzoli I, Anesi E, Perfetti V, Marinone G. Merlini G, et al. Among authors: perfetti v. Clin Exp Rheumatol. 1995 Nov-Dec;13 Suppl 13:S71-3. Clin Exp Rheumatol. 1995. PMID: 8730480 Review.

10

Membrane CD22 defines circulating myeloma-related cells as mature or later B cells.

Perfetti V, Vignarelli MC, Bellotti V, Glennie MJ, Zorzoli I, Ubbiali P, Obici L, Massa M, Ippoliti G, Ascari E, Merlini G. Perfetti V, et al. Lab Invest. 1997 Oct;77(4):333-44. Lab Invest. 1997. PMID: 9354768

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters